(Q33856581)

29 July 2017

title

Alpha interferon and ribavirin combination therapy of chronic hepatitis D. (English)

1 reference

29 July 2017

1 reference

1 reference

9

Yilmaz Cakaloglu

0 references

author name string

Sabahattin Kaymakoglu

1

1 reference

29 July 2017

Cetin Karaca

2

1 reference

29 July 2017

Kadir Demir

3

1 reference

29 July 2017

Sule Poturoglu

4

1 reference

29 July 2017

Ahmet Danalioglu

5

1 reference

29 July 2017

Selim Badur

6

1 reference

29 July 2017

Murvet Bozaci

7

1 reference

29 July 2017

Fatih Besisik

8

1 reference

29 July 2017

Yilmaz Cakaloglu

9

1 reference

29 July 2017

Atilla Okten

10

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

published in

1 reference

29 July 2017

volume

49

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

1135-1138

1 reference

The predominance of hepatitis delta virus genotype I among chronically infected Italian patients

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549218

Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549218

Ribavirin treatment for chronic hepatitis D: a pilot study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549218

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549218

Hepatitis delta virus infection of the liver

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549218

Use of α-interferon in the treatment of chronic delta hepatitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549218

Rapid and simple method for purification of nucleic acids

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549218

Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549218

Famciclovir treatment of chronic delta hepatitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549218

Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549218

Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549218

The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549218

Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy

29 October 2018

1 reference

12 December 2020

Changing pattern of chronic hepatitis D in Southern Europe

1 reference

12 December 2020

Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment

1 reference

12 December 2020

Alpha lymphoblastoid interferon and acyclovir for chronic hepatitis delta

1 reference

12 December 2020

A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study

1 reference

12 December 2020

Treatment of chronic hepatitis D with interferon alfa-2a

1 reference

12 December 2020

The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial

1 reference

12 December 2020

10.1128/AAC.49.3.1135-1138.2005

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference